Indo-Bangla Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 103.39 million compared to BDT 144.35 million a year ago. Net income was BDT 1.01 million compared to BDT 13.44 million a year ago. Basic earnings per share from continuing operations was BDT 0.01 compared to BDT 0.12 a year ago.
For the nine months, sales was BDT 325.33 million compared to BDT 435.23 million a year ago. Net income was BDT 11.87 million compared to BDT 71.64 million a year ago. Basic earnings per share from continuing operations was BDT 0.1 compared to BDT 0.62 a year ago.